breast cancer

  2. breast cancer

CLINICAL CASE: SYNCHRONOUS MALIGNANCY: LEFT BREAST AND OVARIAN CANCER ASSOCIATED WITH HEREDITARY BRCA1: 5382 INS C – MUTATION

Kravchenko O. V., Bashtan O. P., Chornobai A. V., Mukovoz O. E., Hahal O. V.
2023 Issue 2, 169 BRCA 1\2 mutation breast cancer development risk heredity ovarian cancer

MICROBIOTA OF THE RESPIRATORY TRACT IN PATIENTS WITH BREAST CANCER ASSOCIATED WITH INFECTIOUS-INFLAMMATORY COMPLICATIONS

Aliyev M. H., Khalilov F. F.
2024 Issue 3, 174 breast cancer infectious-inflammatory complications microorganisms respiratory system

THE APPLICATION OF ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF BREAST CANCER: BIBLIOMETRIC ANALYSIS

Lakhtaryna R. Yu.
2024 Issue 4, 175 artificial intelligence BI-RADS scale bibliometric analysis breast cancer screening

NAV1.5: ATYPICAL FUNCTIONS OF VOLTAGE-GATED SODIUM CHANNELS IN TUMOR CELLS AND NEW PERSPECTIVES IN THE TREATMENT OF BREAST CANCER

Tkachenko S. S., Rodynskyi O. H., Portniaha M. M.
2025 Issue 4, 179 breast cancer E3Ab invasion metastasis NaV 1.5 inhibitors Nav1.5 nNav1.5 voltage-gated sodium channel

MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS AND MOLECULAR PROFILE OF BREAST CANCER: ROLE IN THE CHOICE AND EFFECTIVENESS OF NEOADUVANT SYSTEMIC THERAPY AND PROGNOSTIC SIGNIFICANCE

Romanukha K. H., Zavizion V. F.
2025 Issue 4, 179 breast cancer immunohistochemical analysis Ki-67 morphological characteristics of tumors treatment tactics